A
Anebulo Pharmaceuticals D
D
ANEB
1.53000
USD
0.04
(2.68%)
مغلق
حجم التداول
61
الربح لكل سهم
-0
العائد الربحي
-
P/E
-6
حجم السوق
62,859,638
العنوان: Anebulo Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.